Literature DB >> 11352305

Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations.

D A Wirtzfeld1, N J Petrelli, M A Rodriguez-Bigas.   

Abstract

UNLABELLED: Hamartomatous polyposis syndromes are characterized by an overgrowth of cells or tissues native to the area in which they normally occur. Juvenile polyposis syndrome (JPS) results from germ-line mutations in the SMAD-4 gene (18q21.1) that encodes for an enzyme involved in transforming growth factor beta(TGF-beta) signal transduction. The increased neoplastic risk may result from SMAD-4 mutations in the stromal component, which stimulate epithelial dysplasia and progression to invasive malignancy. Peutz-Jeghers syndrome (PJS) is associated with germ-line mutations in the LKB1 gene (19p13.3) that encodes a multifunctional serine-threonine kinase. These mutations occur in the epithelial component, suggesting a direct tumor suppressor effect. Patients are at an increased risk of intestinal and extraintestinal malignancies, including breast, pancreatic, ovarian, testicular, and cervical cancer. Cowden's disease is associated with germ-line mutations in the PTEN gene (10q22-23) and an increased risk of breast and thyroid malignancies. Ruvalcaba-Myhre-Smith syndrome is less common; controversy suggests that it may represent a variant of Cowden's disease.
CONCLUSIONS: Genetic alterations underlying hamartomatous polyposis syndromes are diverse. Carcinogenesis may result from either germ-line mutations in the stroma (JPS) or as a direct result of functional deletion of tumor suppressor genes (PJS). Diagnosis depends on clinical presentation and patterns of inheritance within families. Suggested surveillance guidelines for the proband and first-degree relatives are outlined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352305     DOI: 10.1007/s10434-001-0319-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  31 in total

1.  [Peutz-Jeghers syndrome : not only a polyposis!].

Authors:  S Greven; R Fölster-Holst
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751

2.  Intussusception in the adult: an unsuspected case of Peutz-Jeghers syndrome with review of the literature.

Authors:  Jason D Fraser; Steven E Briggs; Shawn D St Peter; Giovanni De Petris; Jacques Heppell
Journal:  Fam Cancer       Date:  2008-08-23       Impact factor: 2.375

Review 3.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 4.  Colorectal cancer risk in hamartomatous polyposis syndromes.

Authors:  Fábio Guilherme Campos; Marleny Novaes Figueiredo; Carlos Augusto Real Martinez
Journal:  World J Gastrointest Surg       Date:  2015-03-27

Review 5.  Activin receptor-like kinases: a diverse family playing an important role in cancer.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

6.  Laparoscopy adjuvant total colorectal resection for the treatment of familial adenomatous polyposis (FAP).

Authors:  Z Zhang; D Wang; C Xu; Y Yu; Y Li; X Zhang
Journal:  Clin Transl Oncol       Date:  2018-11-21       Impact factor: 3.405

7.  Polyps in children.

Authors:  Vincent R Adolph; Kathryn Bernabe
Journal:  Clin Colon Rectal Surg       Date:  2008-11

8.  Extracolonic manifestations of hereditary colorectal cancer syndromes.

Authors:  Daniel A Anaya; George J Chang; Miguel A Rodriguez-Bigas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

9.  Clinical utility of array comparative genomic hybridization: uncovering tumor susceptibility in individuals with developmental delay.

Authors:  Margaret P Adam; April N Justice; Susan Schelley; Andrea Kwan; Louanne Hudgins; Christa L Martin
Journal:  J Pediatr       Date:  2009-01       Impact factor: 4.406

10.  Juvenile polyposis syndrome.

Authors:  Vijai D Upadhyaya; A N Gangopadhyaya; S P Sharma; S C Gopal; D K Gupta; Vijayendra Kumar
Journal:  J Indian Assoc Pediatr Surg       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.